Corporate ActionJul 13, 2026, 09:31 PM
Autonomix Medical Secures $2.6M from Warrant Exercise
AI Summary
Autonomix Medical, Inc. announced a warrant inducement agreement with an investor for the immediate exercise of outstanding November 2025 Warrants. This transaction is expected to generate approximately $2.6 million in gross proceeds for the company. In consideration, Autonomix will issue new Series D-1 and Series D-2 warrants to the investor, each exercisable at $5.75 per share.
Key Highlights
- Autonomix Medical entered a warrant inducement agreement with an investor.
- Investor to exercise 428,731 November 2025 Warrants at $6.00 per share.
- Expected gross proceeds of approximately $2.6 million from warrant exercise.
- Company to issue 428,731 Series D-1 and 428,731 Series D-2 New Warrants.
- New Warrants have an exercise price of $5.75 per share and expire in 5.5 years.
- Closing of the warrant exercise transaction is expected around July 15, 2026.
Price Impact
More from AMIX